Contraceptives are hormone-based medicines that contain progestin, which is a kind of oestrogen. Birth control, often known as hormonal birth control, comes in a box and is taken once a day by the user. Contraceptives are usually safe, cheap, and effective, especially if women take the pill on time and as directed. Aside from preventing pregnancy, the pill provides a slew of other health advantages. Improved cholesterol levels, lower blood pressure, less body hair, less acne, decreased oestrogen levels, and more are just a few of the many advantages of contraception. Contraceptives aren't always effective. However, if all you want is a kid, a natural option should be considered.
Contraceptives containing the hormones oestrogen and progesterone are the most common way for preventing pregnancy. Combination pills are what they're called. The disadvantage of this kind of contraception is that oestrogen and progesterone are still present. And these two hormones work in tandem to change vaginal secretions. Another disadvantage is that combining these two can reduce their efficacy. If somebody is thinking about using contraceptives, it's crucial to know what kind of pills they're using, because not all pills are created equal. Low-dose progestin-containing contraceptives can be particularly successful for women who have a history of ovarian cancer or other major health problems. Combination contraceptives, which include a low-dose type of progestin as well as an active component to prevent blood clots, are also quite successful.
Read More: https://bit.ly/3nhBN8W
Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with rising preference for minimally invasive procedures; increasing investments, funds, and grants by public-private organizations for research; and technological advancements in the market will fuel the market growth over the forecast period.The embolotherapy devices market is projected to reach USD 4.9 billion by 2024 from USD 3.3 billion in 2019, at a CAGR of 8.1% from 2019 to 2024.The growth of the embolotherapy market is mainly attributed to factors such as the growth in the target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement scenario.The embolic agents segment accounted for the largest share of the embolotherapy devices market, by product, in 2019Based on product, the embolotherapy market is segmented into embolic agents (embolic coils, embolic plug systems, liquid embolic agents, microspheres, and detachable balloons) and support devices (microcatheters and guidewires).
Microspheres accounted for the largest share of the embolotherapy market in 2018.
Market growth in this segment is attributed to the surge in the prevalence of hepatocellular carcinoma (microspheres are widely used to treat this disease), coupled with favorable reimbursement criteria in developed economies.Download PDF Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=185897830The cancer segment is projected to hold the largest share of the market by disease indication during the forecast period of 2019 to 2024By disease indication, the embolotherapy market is classified into cancer, peripheral vascular diseases, neurological diseases, urological & nephrological disorders, and gastrointestinal disorders.
The cancer segment held the largest share of the embolotherapy market in 2019.
The rising preference for minimally invasive procedures, expansion of the target patient population, growing public-private funding & government support for cancer research, and technological advancements in the field of microspheres are driving the growth of this segment.Hospitals and clinics were the key end users in the embolotherapy devices marketOn the basis of end users, the embolotherapy market is segmented into hospitals and clinics, ambulatory surgery centers (ASCs), and other end users.
In 2018, the hospital and clinics segment held the largest share of the embolotherapy market.
